Financial reports
10-Q
2019 Q3
Quarterly report
7 Nov 19
10-Q
2019 Q2
Quarterly report
8 Aug 19
10-Q
2019 Q1
Quarterly report
10 May 19
10-K/A
2018 FY
Annual report (amended)
30 Apr 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
6 Nov 18
10-Q
2018 Q2
Quarterly report
8 Aug 18
10-Q
2018 Q1
Quarterly report
8 May 18
10-K
2017 FY
Annual report
27 Feb 18
10-Q
2017 Q3
Quarterly report
7 Nov 17
Current reports
8-K
Termination of a Material Definitive Agreement
17 Dec 19
8-K
Submission of Matters to a Vote of Security Holders
5 Sep 19
8-K
Entry into a Material Definitive Agreement
8 Jul 19
8-K
Spark Therapeutics Enters into Definitive Merger Agreement with Roche
25 Feb 19
8-K
Spark Therapeutics Reports 2018 Financial Results and Recent Business Progress
19 Feb 19
8-K
Results of Operations and Financial Condition
7 Jan 19
8-K
Other Events
23 Nov 18
8-K
Departure of Directors or Certain Officers
15 Nov 18
8-K
Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress
6 Nov 18
8-K
Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress
7 Aug 18
Registration and prospectus
15-12B
Securities registration termination
27 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 19
25-NSE
Exchange delisting
17 Dec 19
SC 14D9/A
Tender offer solicitation (amended)
17 Dec 19
SC TO-T/A
Third party tender offer statement (amended)
17 Dec 19
SC 14D9/A
Tender offer solicitation (amended)
16 Dec 19
Proxies
DEFA14A
Additional proxy soliciting materials
27 Aug 19
DEFA14A
Additional proxy soliciting materials
24 Jul 19
DEF 14A
Definitive proxy
22 Jul 19
DEF 14A
Definitive proxy
20 Apr 18
DEFA14A
Additional proxy soliciting materials
20 Apr 18
DEFA14A
Additional proxy soliciting materials
15 May 17
DEFA14A
Additional proxy soliciting materials
24 Apr 17
DEF 14A
Definitive proxy
21 Apr 17
DEF 14A
Definitive proxy
21 Apr 16
Other
CT ORDER
Confidential treatment order
13 Dec 19
CT ORDER
Confidential treatment order
13 Dec 19
CT ORDER
Confidential treatment order
21 Mar 19
CT ORDER
Confidential treatment order
21 Mar 19
UPLOAD
Letter from SEC
19 Mar 19
CORRESP
Correspondence with SEC
27 Feb 19
UPLOAD
Letter from SEC
25 Feb 19
CORRESP
Correspondence with SEC
19 Feb 19
UPLOAD
Letter from SEC
13 Feb 19
CORRESP
Correspondence with SEC
28 Jan 19
Ownership
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
3
Initial statement of insider ownership
18 Dec 19
4
Lota S. Zoth
17 Dec 19
4
Lisa Dalton
17 Dec 19
4
Stephen W Webster
17 Dec 19
4
ELLIOT SIGAL
17 Dec 19
4
ROBERT J PEREZ
17 Dec 19
4
VINCENT MILANO
17 Dec 19
4
Anand Mehra
17 Dec 19
4
Federico Mingozzi
17 Dec 19